Abstract:Cardiac CT has developed into a robust clinical tool during the past 15 years. Of the fields in which the potential of cardiac CT has raised more interest is chest pain in acute settings. In fact, the possibility to exclude with high reliability obstructive coronary artery disease (CAD) in patients at low-to-intermediate risk is of great interest both from the clinical standpoint and from the management standpoint. Several other modalities, with or without imaging, have been used during the past decades in the… Show more
“…MRI is the most versatile imaging modality: it can be used for morphology, function, viability, and quantitative myocardial perfusion assessment [ 100 ]. Stress perfusion MRI performs better than SPECT for diagnosis of obstructive CAD, as reported in two large prospective randomized studies (MR-IMPACT and CE-MARC trials), and yields a similar diagnostic accuracy as PET, with a poll sensitivity of 89% and specificity of 76% [ 100 ]. Moreover spatial resolution of perfusion MRI (1-2 mm) is superior to that of SPECT, especially for the detection of subendocardial perfusion abnormalities [ 37 ].…”
Section: Comparison With Other Noninvasive Techniques For Myocardimentioning
confidence: 99%
“…Moreover spatial resolution of perfusion MRI (1-2 mm) is superior to that of SPECT, especially for the detection of subendocardial perfusion abnormalities [ 37 ]. Despite these excellent features, limitations to the clinical routine implementation of MRI perfusion assessment are the time-consuming image acquisition, the limited accessibility, and lack of widespread competence in cardiac MRI [ 37 , 100 ].…”
Section: Comparison With Other Noninvasive Techniques For Myocardimentioning
confidence: 99%
“…The introduction of ultrasound contrast agents (microbubbles) has optimized the detection of RWMA and has enabled simultaneous assessment of left ventricular perfusion and viability, improving the sensitivity of the technique [ 100 ].…”
Section: Comparison With Other Noninvasive Techniques For Myocardimentioning
The past two decades have witnessed rapid and remarkable technical improvement of multidetector computed tomography (CT) in both image quality and diagnostic accuracy. These improvements include higher temporal resolution, high-definition and wider detectors, the introduction of dual-source and dual-energy scanners, and advanced postprocessing. Current new generation multidetector row (≥64 slices) CT systems allow an accurate and reliable assessment of both coronary epicardial stenosis and myocardial CT perfusion (CTP) imaging at rest and during pharmacologic stress in the same examination. This novel application makes CT the unique noninvasive “one-stop-shop” method for a comprehensive assessment of both anatomical coronary atherosclerosis and its physiological consequences. Myocardial CTP imaging can be performed with different approaches such as static arterial first-pass imaging, and dynamic CTP imaging, with their own advantages and disadvantages. Static CTP can be performed using single-energy or dual-energy CT, employing qualitative or semiquantitative analysis. In addition, dynamic CTP can obtain quantitative data of myocardial blood flow and coronary flow reserve. The purpose of this review was to summarize all available evidence about the emerging role of myocardial CTP to identify ischemia-associated lesions, focusing on technical considerations, clinical applications, strengths, limitations, and the more promising future fields of interest in the broad spectra of ischemic heart disease.
“…MRI is the most versatile imaging modality: it can be used for morphology, function, viability, and quantitative myocardial perfusion assessment [ 100 ]. Stress perfusion MRI performs better than SPECT for diagnosis of obstructive CAD, as reported in two large prospective randomized studies (MR-IMPACT and CE-MARC trials), and yields a similar diagnostic accuracy as PET, with a poll sensitivity of 89% and specificity of 76% [ 100 ]. Moreover spatial resolution of perfusion MRI (1-2 mm) is superior to that of SPECT, especially for the detection of subendocardial perfusion abnormalities [ 37 ].…”
Section: Comparison With Other Noninvasive Techniques For Myocardimentioning
confidence: 99%
“…Moreover spatial resolution of perfusion MRI (1-2 mm) is superior to that of SPECT, especially for the detection of subendocardial perfusion abnormalities [ 37 ]. Despite these excellent features, limitations to the clinical routine implementation of MRI perfusion assessment are the time-consuming image acquisition, the limited accessibility, and lack of widespread competence in cardiac MRI [ 37 , 100 ].…”
Section: Comparison With Other Noninvasive Techniques For Myocardimentioning
confidence: 99%
“…The introduction of ultrasound contrast agents (microbubbles) has optimized the detection of RWMA and has enabled simultaneous assessment of left ventricular perfusion and viability, improving the sensitivity of the technique [ 100 ].…”
Section: Comparison With Other Noninvasive Techniques For Myocardimentioning
The past two decades have witnessed rapid and remarkable technical improvement of multidetector computed tomography (CT) in both image quality and diagnostic accuracy. These improvements include higher temporal resolution, high-definition and wider detectors, the introduction of dual-source and dual-energy scanners, and advanced postprocessing. Current new generation multidetector row (≥64 slices) CT systems allow an accurate and reliable assessment of both coronary epicardial stenosis and myocardial CT perfusion (CTP) imaging at rest and during pharmacologic stress in the same examination. This novel application makes CT the unique noninvasive “one-stop-shop” method for a comprehensive assessment of both anatomical coronary atherosclerosis and its physiological consequences. Myocardial CTP imaging can be performed with different approaches such as static arterial first-pass imaging, and dynamic CTP imaging, with their own advantages and disadvantages. Static CTP can be performed using single-energy or dual-energy CT, employing qualitative or semiquantitative analysis. In addition, dynamic CTP can obtain quantitative data of myocardial blood flow and coronary flow reserve. The purpose of this review was to summarize all available evidence about the emerging role of myocardial CTP to identify ischemia-associated lesions, focusing on technical considerations, clinical applications, strengths, limitations, and the more promising future fields of interest in the broad spectra of ischemic heart disease.
“…Computed tomography of the coronary arteries is an accurate noninvasive diagnostic test for coronary artery disease [59]. In addition, it provides information on cardiac valves and chambers [60].…”
Ischemic cardiomyopathy, disease of the heart muscle due to coronary artery disease, is the most common cardiomyopathy. It is often difficult to discern the etiology of heart failure, and often there are multiple underlying causes. Ischemic cardiomyopathy most often presents with a dilated morphology with wall motion defects and a history of previous myocardial infarction or confirmed coronary artery disease. Mechanisms of myocardial depression in ischemia are necrosis of myocardial cells resulting in irreversible loss of function or reversible damage, either short term through myocardial stunning or long term through hibernation. In ischemic cardiomyopathy, echocardiography may be extended with stress testing or other imaging modalities such as myocardial scintigraphy and cardiac magnetic resonance tomography. Coronary angiography is often considered a gold standard; however, other modalities such as positron emission tomography can be needed to detect small vessel disease. Cardiac revascularization, through percutaneous coronary intervention and coronary artery bypass grafting, both in acute coronary syndrome and in stable coronary artery disease, relieves symptoms and improves prognosis. Therapy should aspire to treat ischemia, arrhythmias in addition to heart failure management, which includes device therapy with cardiac resynchronization therapy, implantable cardioverter defibrillators, and mechanical support as bridging or destination therapy in end-stage disease.
“…Despite promising results, to date the clinical usefulness of noninvasive subclinical atherosclerosis evaluation in asymptomatic at‐risk individuals is still debated. The role of coronary computed tomography angiography (CCTA) in symptomatic patients is delineated, but it is still unknown in asymptomatic individuals with significant atherosclerosis because of a paucity of data . Accordingly, the aim of the study was to assess the prognostic benefit of carotid artery disease by ultrasound technique and subclinical coronary artery disease (CAD) using CCTA in an asymptomatic at‐risk adult population.…”
In an asymptomatic population, CAD and plaque positive remodeling increase MACE prediction compared with a model based on 10-year FRS, carotid disease, and CACS estimation. In the diabetes subgroup, percentage of segments with remodeled plaque was the only predictor of MACE.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.